CN106333291A - 一种桑葚口崩片 - Google Patents
一种桑葚口崩片 Download PDFInfo
- Publication number
- CN106333291A CN106333291A CN201610738686.3A CN201610738686A CN106333291A CN 106333291 A CN106333291 A CN 106333291A CN 201610738686 A CN201610738686 A CN 201610738686A CN 106333291 A CN106333291 A CN 106333291A
- Authority
- CN
- China
- Prior art keywords
- mulberries
- mulberry
- lactose
- disintegrating tablet
- microcrystalline cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000008708 Morus alba Nutrition 0.000 title claims abstract description 56
- 240000000249 Morus alba Species 0.000 title abstract description 20
- 239000006191 orally-disintegrating tablet Substances 0.000 title abstract 4
- 241000218231 Moraceae Species 0.000 claims abstract description 37
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 22
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 16
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 16
- 239000008101 lactose Substances 0.000 claims abstract description 16
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 16
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 16
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 16
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 14
- 229930195725 Mannitol Natural products 0.000 claims abstract description 14
- 239000000594 mannitol Substances 0.000 claims abstract description 14
- 235000010355 mannitol Nutrition 0.000 claims abstract description 14
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims abstract description 14
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims abstract description 14
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 11
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 14
- 235000013399 edible fruits Nutrition 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 8
- 229960003080 taurine Drugs 0.000 claims description 7
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 9
- 230000004438 eyesight Effects 0.000 abstract description 8
- 206010033557 Palpitations Diseases 0.000 abstract description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 206010022437 insomnia Diseases 0.000 abstract description 4
- 208000003464 asthenopia Diseases 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 101150107521 eat-20 gene Proteins 0.000 description 1
- 101150010415 eat-5 gene Proteins 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- DKXULEFCEORBJK-UHFFFAOYSA-N magnesium;octadecanoic acid Chemical compound [Mg].CCCCCCCCCCCCCCCCCC(O)=O DKXULEFCEORBJK-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 230000000701 neuroleptic effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及一种桑葚口崩片,属于食品技术领域。本发明的技术方案是:一种桑葚口崩片,其特征在于,每1000片中,含有干桑葚150‑300g,乳糖20‑38g,甘露醇50‑80g,微晶纤维素40‑68g,交联聚维酮K30 6‑10g,硬脂酸镁0.7‑1.5g。有益效果:本发明产品方面在任何时间食用,且具有增强免疫力;还具有增强视力;消除眼睛疲劳;通便;治疗心悸失眠等作用。
Description
技术领域
本发明涉及一种桑葚口崩片,属于食品技术领域。
背景技术
桑椹,又名桑椹子、桑葚、桑蔗、桑枣、桑果、乌椹等,为桑科植物桑的果穗。桑椹嫩时色青,味酸,老熟时色紫黑,多汁,味甜。成熟的桑椹果营养丰富,每100克桑椹含水分81.8克,蛋白质1.8克,脂肪0.3克,纤维素4.9克,碳水化合物10克,,胡萝卜素30微克,锌0.27毫克,铜0.08毫克,硒4.8微克,核黄素0.06毫克,维生素 E6.95毫克,钾33毫克,花青素66mg。
桑葚有改善皮肤(包括头皮)血液供应,营养肌肤,使皮肤白嫩及乌发等作用,并能延缓衰老。桑葚是中老年人健体美颜、抗衰老的佳果与良药。常食桑椹可以明目,缓解眼睛疲劳干涩的症状。桑葚具有免疫促进作用。桑葚对脾脏有增重作用,对溶血性反应有增强作用,可防止人体动脉硬化、骨骼关节硬化,促进新陈代谢。它可以促进血红细胞的生长,防止白细胞减少,并对治疗糖尿病、贫血、高血压、高血脂、冠心病、神经衰弱等病症具有辅助功效。桑椹具有生津止渴、促进消化、帮助排便等作用,适量食用能促进胃液分泌,刺激肠蠕动及解除燥热。祖国医学认为,桑葚性味甘寒,具有补肝益肾、生津润肠、乌发明目等功效。
中医学认为桑椹补益肝肾,滋阴养血,息风,具有主治心悸失眠、头晕目眩、耳鸣、便秘盗汗、关节不利等病症。
由于桑葚含水量很高,所以,成熟的果子保存时间不超过24小时,因此,市售鲜果的时间非常短,在北方,也就前后十几天的市售时间,一般是当天买,当天食用。放置到第二天,就会腐败。因此,虽然桑葚营养丰富,但很少有大面积种植的,学生和上班族也很少有空去购买食用的情况。
发明内容
发明目的:本发明的目的是提供一种桑葚口崩片,方便学生、上班族等群体食用。
本发明的技术方案是:一种桑葚口崩片,其特征在于,每1000片中,含有干桑葚150-300g,乳糖20-38g,甘露醇50-80g,微晶纤维素40-68g,交联聚维酮K30 6-10g,硬脂酸镁0.7-1.5g。
本发明优选的技术方案是:一种桑葚口崩片,其特征在于,每1000片中,还含有每牛磺酸10-30g。牛磺酸的加入,对保护食用者的视力有一定的作用。
本发明口崩片,还可以添加蔗糖调整口味。
本发明优选的技术方案是:一种桑葚口崩片,其特征在于,每1000片中,含有干桑葚180-280g,乳糖25-36g,甘露醇55-75g,微晶纤维素45-62g,交联聚维酮K30 7-10g,硬脂酸镁0.7-1.5g。
本发明优选的技术方案是:一种桑葚口崩片,其特征在于,每1000片中,含有干桑葚180g,乳糖25g,甘露醇55g,微晶纤维素452g,交联聚维酮K30 7g,硬脂酸镁0.7g。
本发明优选的技术方案是:一种桑葚口崩片,其特征在于,每1000片中,含有干桑葚280g,乳糖36g,甘露醇75g,微晶纤维素62g,交联聚维酮K30 10g,硬脂酸镁1.5g。
本发明优选的技术方案是:一种桑葚口崩片,其特征在于,每1000片中,含有干桑葚230g,乳糖30g,甘露醇60g,微晶纤维素50g,交联聚维酮K30 9g,硬脂酸镁1g。
本发明技术方案中,所述桑葚为烘干后的桑葚。
本发明桑葚口崩片的制备方法,其特征在于,
第一步 成熟的桑葚果子烘干,粉碎至过100目筛;
第二步 处方中的其他原辅料,过100目筛;
第三步 按处方量称取各种组分,混合均匀,压片。
本发明产品每日5-10片,直接放入口中食用。
有益效果:本发明产品方面在任何时间食用,且具有增强免疫力;还具有增强视力;消除眼睛疲劳;通便;治疗心悸失眠等作用。
实施例1、桑葚150-300g,乳糖20-38g,甘露醇50-80g,微晶纤维素40-68g,交联聚维酮K30 6-10g,硬脂酸镁0.7-1.5g,按技术方案所描述的制备方法制备1000片。
实施例2、桑葚150-300g,乳糖20-38g,甘露醇50-80g,微晶纤维素40-68g,交联聚维酮K30 6-10g,硬脂酸镁0.7-1.5g,牛磺酸10g,按技术方案所描述的制备方法制备1000片。
实施例3、桑葚180g,乳糖25g,甘露醇55g,微晶纤维素452g,交联聚维酮K30 7g,硬脂酸镁0.7g,牛磺酸30g,按技术方案所描述的制备方法制备1000片。
实施例4、桑葚280g,乳糖36g,甘露醇75g,微晶纤维素62g,交联聚维酮K30 10g,硬脂酸镁1.5g,牛磺酸20g,按技术方案所描述的制备方法制备1000片。
实施例5、桑葚230g,乳糖30g,甘露醇60g,微晶纤维素50g,交联聚维酮K30 9g,硬脂酸镁1g,牛磺酸25g,按技术方案所描述的制备方法制备1000片。
试验例1、办公室电脑族,诉说有眼睛干涩且便秘症状100人,随机分为5组,每组20人,食用本发明实施例1-5的产品,初始每日10片,食用20天,眼睛干涩、便秘症状全部消失。之后,每日食用5片连续食用3个月,期间症状不复发。
试验例2、初中学生100人,随机分为5组,每组20人,记录每位学生的视力,食用本发明实施例1-5的产品,刚开始一个月,每日10片,1个月后,减至每日6片,连续服用6个月,记录视力变化和感冒次数:食用本发明实施例2-5产品的学生,视力没有变化,食用实施例1产品的学生,有2人视力下降;食用实施例1-5产品的学生,有6人次感冒,且症状较轻,恢复较快。而没有服用本发明产品的学生,有5人视力呈不同程度的下滑,有16人次感冒,其中有2例需要到医院输液治疗。
试验例3、门诊收治40-55岁主诉有头昏、心悸失眠症状患者100人,随机分为5组,每组20人,分别服用本发明实施例1-5产品,每日10片,食用10天后大部分患者症状减轻,30天后全部症状消失。维持使用量为每日6片,跟踪2个月,没有复发。
Claims (7)
1.一种桑葚口崩片,其特征在于,每1000片中,含有干桑葚150-300g,乳糖20-38g,甘露醇50-80g,微晶纤维素40-68g,交联聚维酮K30 6-10g,硬脂酸镁0.7-1.5g。
2.权利要求1所述口崩片,其特征在于,每1000片中,含有干桑葚180-280g,乳糖25-36g,甘露醇55-75g,微晶纤维素45-62g,交联聚维酮K30 7-10g,硬脂酸镁0.7-1.5g。
3.权利要求1所述口崩片,其特征在于,每1000片中,含有干桑葚180g,乳糖25g,甘露醇55g,微晶纤维素452g,交联聚维酮K30 7g,硬脂酸镁0.7g。
4.权利要求1所述桑葚口崩片,其特征在于,每1000片中,含有干桑葚280g,乳糖36g,甘露醇75g,微晶纤维素62g,交联聚维酮K30 10g,硬脂酸镁1.5g。
5.权利要求1所述口崩片,其特征在于,每1000片中,含有干桑葚230g,乳糖30g,甘露醇60g,微晶纤维素50g,交联聚维酮K30 9g,硬脂酸镁1g。
6.权利要求1-5所述口崩片,其特征在于,每1000片中,还含有10-30g牛磺酸。
7.权利要求1-5所述口崩片的制备方法,其特征在于,
第一步 成熟的桑葚果子烘干,粉碎至过100目筛;
第二步 处方中的其他原辅料,过100目筛;
第三步 按处方量称取各种组分,混合均匀,压片。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610738686.3A CN106333291A (zh) | 2016-08-29 | 2016-08-29 | 一种桑葚口崩片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610738686.3A CN106333291A (zh) | 2016-08-29 | 2016-08-29 | 一种桑葚口崩片 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106333291A true CN106333291A (zh) | 2017-01-18 |
Family
ID=57822732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610738686.3A Pending CN106333291A (zh) | 2016-08-29 | 2016-08-29 | 一种桑葚口崩片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106333291A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111685324A (zh) * | 2020-06-05 | 2020-09-22 | 郑思念 | 一种通便、助眠、提升免疫力的组合物及制法和应用 |
-
2016
- 2016-08-29 CN CN201610738686.3A patent/CN106333291A/zh active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111685324A (zh) * | 2020-06-05 | 2020-09-22 | 郑思念 | 一种通便、助眠、提升免疫力的组合物及制法和应用 |
CN111685324B (zh) * | 2020-06-05 | 2024-08-27 | 郑思念 | 一种通便、助眠、提升免疫力的组合物及制法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101828661B (zh) | 一种用于改善皮肤水分、除皱的保健食品 | |
CN103999996A (zh) | 一种保健板栗及其制备方法 | |
CN102919450B (zh) | 一种五谷浸提液凉茶及其制备方法 | |
KR101018065B1 (ko) | 대추를 사용한 건강음료 제조방법 및 이에 의해 제조된 건강음료 | |
CN106860680A (zh) | 金花人参压片糖果及其制备方法 | |
CN107183290A (zh) | 一种黑枸杞压片糖果及其制备方法 | |
CN107455625A (zh) | 一种具有抗疲劳减肥功能的植物营养素饮料及其制备工艺 | |
CN105232907A (zh) | 一种补肾壮阳饮料及其制备方法 | |
CN106974174A (zh) | 一种果蔬复合米粉及其制备方法 | |
CN101669624B (zh) | 一种具有改善妇女贫血功能的中药八宝茶及其制备方法 | |
CN106923130A (zh) | 含西红花的固体饮料、其制备方法及应用 | |
CN104921133A (zh) | 一种女性谷菜果营养食品及其制备方法 | |
CN101152239A (zh) | 一种雄蜂蛹冻干粉冲剂及胶囊的制备工艺 | |
CN107223846A (zh) | 一种适合中老年人的杂粮保健粉 | |
CN105249440A (zh) | 一种阿胶糕 | |
CN105685317A (zh) | 富含硒火麻茶及其制备方法 | |
CN105532991A (zh) | 一种具有养颜美容功能的复合黑茶及其制备方法 | |
CN102940219A (zh) | 一种土豆饼及其制作方法 | |
CN101955874B (zh) | 一种苦杏酒的酿造方法 | |
CN106417817A (zh) | 一种袋泡助眠安神茶及其制备方法 | |
CN107950862A (zh) | 一种红枣羹及其制作方法 | |
CN107384680B (zh) | 一种百香果龙眼果酒及其酿造方法 | |
CN101112605A (zh) | 一种黑豆美容养颜暖醋 | |
CN106333291A (zh) | 一种桑葚口崩片 | |
CN104694315A (zh) | 一种防衰老葡萄酒及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170118 |